BioRestorative Therapies Inc. has announced the pricing of a public offering consisting of 14,285,715 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 14,285,715 shares of common stock. The warrants have an exercise price of $0.35 per share, are immediately exercisable, and will expire five years from the date of issuance. The offering is expected to raise approximately $5.0 million in gross proceeds, which will be used to support clinical trials, pre-clinical research, the development of the company’s biocosmeceuticals platform, and for general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9653479-en) on February 12, 2026, and is solely responsible for the information contained therein.